lenrispodun chemical structure, oral, CNS-penetrant, picomolar PDE1 inhibitor - Intra-Cellular Therapies, New York, NY

oral, CNS-penetrant, picomolar PDE1 inhibitor

Ph. I/II in neurology and heart failure

from literature starting point, LBDD and SBDD

Neuropsychopharmacology

Intra-Cellular Therapies, New York, NY

Context. Lenrispodun (Intra-Cellular Therapies) is a phosphodiesterase (PDE) type 1 (PDE1) inhibitor being developed for CNS and non-CNS disorders, including heart failure, and cancer. Studies to identify PDE inhibitors…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.